Question · asked by 1 review
Zinc vs placebo: Risk of serious adverse events, including those that may be complications of the common cold
- Population
- adults and children with colds and/or upper respiratory infections
- Intervention
- Zinc
- Comparison
- placebo
- Outcome
- Risk of serious adverse events, including those that may be complications of the common cold
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Zinc vs placebo Risk of serious adverse events, including those that may be complications of the common cold · adults and children with colds and/or upper respiratory infections The review found no eligible studies for this question. Zinc for prevention and treatment of the common cold (2024) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Zinc for prevention and treatment of the common cold 2024 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.